A new study from the University of Bath has found that for older adults with atrial fibrillation (AF), stopping blood ...

Atrial Fibrillation (Afib) is a common, yet serious heart condition that requires proper diagnosis and management strategies.

Other studies, particularly this one published in 2021, also point to the potential of bromelain in the treatment of ...

A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...

The Food and Drug Administration (FDA ... approval “will make a direct impact on American patients who rely on anticoagulant medications.” It is unclear when the generics will be available.

Anti-factor XI drugs may prevent thrombosis without compromising physiological hemostasis. "These anticoagulants aim to address gaps not covered by DOACs," noted Isabelle Gouin-Thibault ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...

The other (P-3) was a seventy-eight-year-old man with coronary-artery disease who was unusually resistant to the prothrombinopenic effects of coumarin anticoagulant drugs; this patient was ...

Using a powerful microscopy technique, a team led by researchers at UT Southwestern Medical Center has gained insights into how the body uses vitamin K, an essential nutrient that plays a pivotal role ...

Hyderabad: Endogamy, the practice of marrying within the community, was identified as a primary cause of population-specific diseases.

The results showed that patients taking diltiazem had a 20% higher risk of being hospitalized or dying due to serious ...